Duration of medication for opioid use disorder during pregnancy and postpartum by race/ethnicity

Fig. 1. a. Average proportion of days covered with medication for opioid use disorder, 2016–2019a. b. Average proportion of days covered with buprenorphine, 2016–2019a. c. Average proportion of days covered with methadone, 2016–2019a. aWomen ages 15–50 years with a livebirth or stillbirth (≥20 weeks gestation) in 2016–2019 who were diagnosed with opioid use disorder during pregnancy or at delivery, were enrolled in Medicaid in Delaware, Kentucky, Maine, North Carolina, Pennsylvania, and Wisconsin for ≥8 wee

Dr. Marian Jarlenski's study looked at the duration of medication for opioid use disorder during pregnancy and postpartum by race and ethnicity in Medicaid and found that: 

- There are racial/ethnic inequities in MOUD use during pregnancy.
- Less is known about racial/ethnic inequities in MOUD use postpartum.
- White women had longer duration of MOUD postpartum than Hispanic or Black women.
- Inequities differed by type of MOUD.

Read more about her findings here: https://pubmed.ncbi.nlm.nih.gov/37058829/

Tags